BioMark Diagnostics Obtains Key Canadian and European Patents for Innovative Lung Cancer Blood Test

The company’s patented metabolomics algorithm, validated on over 15,000 samples, advances early detection of non-small cell lung cancer across multiple jurisdictions

IIPLA News Desk•anonymous access•0 articles left this week

BioMark Diagnostics Obtains Key Canadian and European Patents for Innovative Lung Cancer Blood Test

BioMark Diagnostics Inc. has secured formal patent allowances from the Canadian Intellectual Property Office and the European Patent Office for its novel liquid biopsy technology aimed at early-stage lung cancer detection. The patented algorithm, clinically validated on samples from Quebec, France, and Germany, enhanc…

Share This Article

Ready-to-post copy includes the article link.

BioMark Diagnostics Obtains Key Canadian and European Patents for Innovative Lung Cancer Blood Test BioMark Diagnostics Inc. has secured formal patent allowances from the Canadian Intellectual Property Office and the European Patent Office for its novel liquid biopsy technology aimed at early-stage lung cancer detecti... Read the full IIPLA article: https://iipla.org/news/biomark-diagnostics-obtains-key-canadian-and-european-patents-for-innovative-lung-cancer-blood-test

LinkedIn X Facebook WhatsApp Telegram Email

Related Coverage

Continue in the newsroom

Back to newsroom

TrademarksUK

UK Intellectual Property Office Updates Senior Management Structure Through 2026

The UK Intellectual Property Office (IPO) has periodically updated its senior management structure, detailing key appointments and interim roles from 2022 through mid-2026. These updates include changes in director positions overseeing business, international policy, enforcement, trademarks, designs, and transformatio…

Tuesday, June 23, 2026

PatentsUK

UK Patents Update Puts Section and Correction Strategy in Focus

IIPLA reviews the patents implications of Patents, Section, Correction, with practical notes for UK IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Tuesday, June 23, 2026

TrademarksUK

UK Intellectual Property Office Warns Against Paying Misleading Trademark and Patent Invoices

The UK Intellectual Property Office (IPO) has issued a detailed advisory to help trademark, design, and patent holders avoid falling victim to misleading invoices. These unsolicited requests often come from organizations unaffiliated with the IPO, offering costly services that are not required. The IPO urges recipient…

Tuesday, June 23, 2026

PatentsGlobal

Volt Carbon Technologies Reports Strong Shareholder Support and Key Advances in Battery and IP Development at 2026 AGM

At its June 19, 2026 Annual General Meeting, Volt Carbon Technologies Inc. secured unanimous shareholder approval on all resolutions, including director re-elections and continuation of its stock option plan. The company provided updates on significant milestones in lithium metal battery testing, expansion of its inte…

Tuesday, June 23, 2026

BrandsGlobal

Datametrex Subsidiary Paymetrex Rebrands as QuantIP Licensing Corp. to Focus on IP Monetization in Quantum Encryption and Payment Technologies

Datametrex AI Limited announced that its wholly owned subsidiary Paymetrex Payment Solutions Inc. has rebranded as QuantIP Licensing Corp. The name change reflects a strategic shift toward intellectual property licensing and monetization, particularly in payment technologies and emerging quantum encryption solutions.…

Tuesday, June 23, 2026

TrademarksGlobal

HarbourView Equity Partners Amplifies Cultural and IP Engagement at Cannes Lions 2024

HarbourView Equity Partners is set to deepen its involvement at the Cannes Lions International Festival of Creativity from June 23 to 25, 2024. The firm’s expanded presence features a curated series of discussions, live performances, and networking events that emphasize the strategic role of intellectual property and…

Tuesday, June 23, 2026